Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
Public ClinicalTrials.gov record NCT05616221. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 Multi-Phage Therapeutic in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety, phage kinetics, and efficacy of inhaled AP-PA02 administered in subjects with non-cystic fibrosis bronchiectasis and chronic pulmonary Pseudomonas aeruginosa infection.
Study identification
- NCT ID
- NCT05616221
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 48 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 10, 2023 (Actual)
- Primary completion
- Jul 17, 2024 (Actual)
- Completion
- Aug 8, 2024 (Actual)
- Last update posted
- Jan 5, 2026
2023 – 2024
United States locations
- U.S. sites
- 23
- U.S. states
- 19
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Velocity Clinical Research | Mobile | Alabama | 36608 | — |
| Southern California Institute for Respiratory Diseases Cedars-Sinai West Tower | Los Angeles | California | 90048 | — |
| UCONN Health | Farmington | Connecticut | 06030 | — |
| Georgetown University Hospital / Pulmonary Critical Care and Sleep Medicine | Washington D.C. | District of Columbia | 20007 | — |
| Southwest General Healthcare Center | Fort Myers | Florida | 33907 | — |
| TecTum Medical Research, Inc. | Hollywood | Florida | 33024 | — |
| Mayo Clinic/Pulmonary, Critical Care, and Sleep Medicine | Jacksonville | Florida | 32224 | — |
| University of Miami | Miami | Florida | 33146 | — |
| St. Lukes Hospital | Boise | Idaho | 83702 | — |
| The University of Kansas Medical Center / Dept of Medicine | Kansas City | Kansas | 66160 | — |
| Johns Hopkins University School of Medicine | Baltimore | Maryland | 21224 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Rutgers Robert Wood Johnson Medical School | New Brunswick | New Jersey | 08901 | — |
| New York Medical College | Hawthorne | New York | 10595 | — |
| University of Cincinnati - College of Medicine | Cincinnati | Ohio | 45267 | — |
| University Hospitals of Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| University of Pennslyvania | Philadelphia | Pennsylvania | 19104 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37203 | — |
| University of Texas Health Science Center at Tyler | Tyler | Texas | 75708 | — |
| Virginia Commonwealth University (VCU) | Richmond | Virginia | 23298 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05616221, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 5, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05616221 live on ClinicalTrials.gov.